Parent Terms |
Term With Siblings |
Child Terms |
|
(-)-alpha-Methylnoradrenaline
(4E)-3-(benzylamino)-5-phenyl-4-penten-1-ol
1-(4-methoxyphenyl)-2-\{[4-(4-nitrophenyl)butan-2-yl]amino\}ethanol
3,4-Dihydro-2H-pyrido[3,2-b][1,4]oxazine
3-amino-4-(propylamino)cyclobut-3-ene-1,2-dione
3-methylamino-1,2-propanediol
4-(2-aminoethyl)-5-nitrobenzene-1,2-diol
4-(2-aminoethyl)benzene-1,2,3-triol
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol +
4-[2-(dipropylamino)ethyl]benzene-1,2-diol
5-(2-aminoethyl)-6-methylbenzene-1,2,4-triol
5-(methylamino)-3H-1,3,4-thiadiazole-2-thione
5-methyl-n-(pyridin-3-ylmethyl)isoxazol-3-amine
alpha-methylnoradrenaline
bambuterol hydrochloride +
benzphetamine hydrochloride
clenbuterol hydrochloride +
colforsin daropate hydrochloride
dobutamine + A catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure.
N-(1-deoxy-beta-D-fructopyranos-1-yl)amine(1+)
N-(3,3-dimethylbutyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
N-(cyclohexylmethyl)-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
N-methyl-5-pyridin-4-yl-1,3,4-thiadiazol-2-amine
N-methyl-6-phenyl-3-(2-pyridinyl)-1,2,4-triazin-5-amine
olodaterol hydrochloride +
oxymetazoline hydrochloride
secondary aliphatic amine +
tetrahydrozoline hydrochloride
|
|
|
Synonyms |
Exact Synonyms: |
4-(2-{[4-(4-hydroxyphenyl)butan-2-yl]amino}ethyl)benzene-1,2-diol
|
Related Synonyms: |
(+-)-4-(2-((3-(p-hydroxyphenyl)-1-methylpropyl)amino)ethyl)pyrocatechol
;
3,4-dihydroxy-N-[3-(4-hydroxyphenyl)-1-methylpropyl]-beta-phenylethylamine
;
4-{2-[3-(4-Hydroxy-phenyl)-1-methyl-propylamino]-ethyl}-benzene-1,2-diol
;
DL-dobutamine
;
Formula=C18H23NO3
;
InChI=1S/C18H23NO3/c1-13(2-3-14-4-7-16(20)8-5-14)19-11-10-15-6-9-17(21)18(22)12-15/h4-9,12-13,19-22H,2-3,10-11H2,1H3
;
InChIKey=JRWZLRBJNMZMFE-UHFFFAOYSA-N
;
SMILES=CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1
;
dobutamina
;
dobutaminum
;
rac-dobutamine
;
racemic-dobutamine
|
Alternate IDs: |
CHEBI:184505
;
CHEBI:554519
|
Xrefs: |
Beilstein:2946389
;
CAS:34368-04-2
;
DrugBank:DB00841
;
Drug_Central:937
;
HMDB:HMDB0014979
;
KEGG:C06967
;
KEGG:D03879
;
LINCS:LSM-1807
|
Xref Mesh: |
MESH:D004280
|
Xrefs: |
PMID:11280019
;
PMID:11950781
;
PMID:18323735
;
PMID:22537238
;
Patent:DE2317710
;
Patent:US3987200
;
Reaxys:2946389
;
Wikipedia:Dobutamine |
|